The Biotech Company That's Training Immune Cells To Fight Cancer

Photo by National Cancer Institute on Unsplash

Dr. Henry Ji, President and CEO of Sorrento Therapeutics SRNE, was a guest speaker at Benzinga’s All Access on March 25, 2022. 

Sorrento Therapeutics is a biotechnology company researching and developing innovative solutions to diseases like cancer, intractable pain and COVID-19.

Watch the full interview here:

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: BiotechPenny StocksSmall CapGeneralPartner ContentSorrento Therapeutics
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!